MB
MBX Biosciences, Inc. Common Stock (MBX)
NASDAQ·Healthcare·Biotechnology
$59.27
-2.81%
Mkt Cap $2.94B
Analyst Ratings
Buy
4
Hold
0
Sell
0
Price Target (12 analysts)
$71.50
Range $56.00 – $90.00
Implied Upside
+20.6%
Consensus $71.50 vs current $59.27